Researchers have identified ECM2-associated ITGB1/FAK-EGFR/ERK adhesion signaling as an experimentally supported mechanism linked to irradiation-stress adaptation in glioblastoma models. Glioblastoma recurrence following radiotherapy is shaped by adaptive malignant states, extracellular matrix remodeling, and adhesion-dependent survival signaling, although extracellular matrix mediators participating in irradiation adaptation have remained incompletely defined. The newly reported findings support an extracellular matrix and adhesion-centered framework wherein ECM2 helps sustain pro-survival adhesion and growth-factor signaling during irradiation stress.
To investigate these mechanisms, the investigators integrated bulk transcriptomic analysis of dataset GSE253464, longitudinal single-cell RNA sequencing of GSE253648, TCGA glioma survival analysis, inferred ligand-receptor analysis, hypothesis-generating virtual perturbation, and transcription-factor activity analysis alongside experimental assays in glioblastoma cell and xenograft models. Bulk transcriptomic analysis identified ECM2 as a therapy-associated adhesion candidate, while longitudinal single-cell sequencing revealed that ECM2-positive malignant states were enriched for extracellular matrix, focal adhesion, mechanotransduction, and irradiation-stress programs. Inferred ligand-receptor analysis and virtual perturbation nominated an ECM2-associated ITGB1/FAK-EGFR/ERK transcriptional axis involving TEAD, AP-1, STAT, and ETS/ELK activity.
In laboratory assays, co-immunoprecipitation detected ECM2 in ITGB1-containing immunoprecipitates, and functional evaluations revealed that ECM2 depletion altered adhesion-associated cytoskeletal organization and reduced YAP/TAZ nuclear localization. Depleting ECM2 also attenuated both basal and EGF-induced FAK/EGFR/ERK signaling while enhancing irradiation-associated γ-H2AX, p21, and cleaved caspase-3 responses. Furthermore, re-expression of ITGB1 restored phosphorylation of FAK, Paxillin, and ERK and partially alleviated irradiation-associated responses, supporting an ITGB1-associated adhesion signaling pathway.
In vivo experiments utilizing an ectopic subcutaneous GSC20 xenograft model demonstrated that ECM2 depletion was associated with reduced tumor growth in the setting of combined temozolomide and local irradiation. The authors concluded that these experimental cell and ectopic xenograft findings support an ECM2-associated mechanism for glioblastoma irradiation-stress adaptation, offering a molecular framework for understanding therapy-adaptive states while noting the in vivo evidence remains grounded in ectopic xenograft models.
Subject of Research: ECM2 adhesion signaling and irradiation-stress adaptation in glioblastoma
Article Title: ECM2-associated ITGB1/FAK-EGFR/ERK adhesion signaling promotes irradiation-stress adaptation in glioblastoma
Article References: Qiao, A., Zhang, Q., Song, F., Cui, T., Liu, Y., & Sun, P. (2026). ECM2-associated ITGB1/FAK-EGFR/ERK adhesion signaling promotes irradiation-stress adaptation in glioblastoma. Biology Direct. https://doi.org/10.1186/s13062-026-01044-3
Image Credits: AI Generated
DOI: 10.1186/s13062-026-01044-3
Keywords: Glioblastoma, ECM2, Radiation Therapy, Adhesion Signaling, ITGB1, FAK, EGFR, Mechanotransduction, ECM2-associated, FAK-EGFR, adhesion, signaling
